Antiheparin activity, activity of factors VII and VIII
Hurlet, A.
Acta Clinica Belgica 32(6): 375-379
1977
ISSN/ISBN: 1784-3286 PMID: 616747 Document Number: 115814
Document emailed within 1 workday
Related Documents
Mahasandana, C.; Suvatte, V.; Püng-amritt, P.; Tuchinda, S. 1979: Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families Southeast Asian Journal of Tropical Medicine and Public Health 10(2): 243-247Takahashi, I.; Furuta, M.; Mizuno, S.; Takamatsu, J.; Kamiya, T. 1993: Effect of substrate and diluent for factor VIIi activity in highly purified factor VIIi concentrate and patient plasma infused factor VIIi concentrate Rinsho Byori. Japanese Journal of Clinical Pathology 41(7): 825-830
Muntean, W. 1984: Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma Wiener Klinische Wochenschrift 96(22): 829-832
Teitel, J.M.; Lau, H.K.; Garvey, M.B. 2002: Discrepancies in measured factor VIIi activity in patients treated with factor VIIi concentrate of human or porcine origin Thrombosis and Haemostasis 88(1): 159-160
Cuervo, J.H.; Rodriguez, B.; Houghten, R.A. 1988: The Magainins: sequence factors relevant to increased antimicrobial activity and decreased hemolytic activity Peptide Research 1(2): 81-86
Bharadwaj, T.P.; Sen, N.K. 1971: "Studies on the levels of fibrinolytic-activity with special reference to its range of activity on various substrates (including coagulation factors) in healthy controls". I Journal of the Association of Physicians of India 19(1): 43-48
Schettini, F.; De Mattia, D.; Altomare, M.; Montagna, O. 1978: Pro-coagulating and antigenic activity of factor VIIi in the newborn born at term Bollettino della Societa Italiana di Biologia Sperimentale 53(24): 2412-2417
Tarasova, L.N.; Khalturina, T.I. 1983: Comparative evaluation of one- and two-step methods of determining factor VIIi activity Laboratornoe Delo 2: 15-18
Olinic, D.; Brudaşcă, I.; Colhon, D.; Stoia, M.; Cucuianu, M. 1996: Increased plasma factor VIII:c activity in patients with unstable angina pectoris Romanian Journal of Internal Medicine 34(1-2): 65-71
Brommer, E.J.; Gevers Leuven, J.A.; Barrett-Bergshoeff, M.M.; Schouten, J.A. 1982: Response to fibrinolytic activity and factor VIII-related antigen to stimulation with desmopressin in hyperlipoproteinemia Journal of Laboratory and Clinical Medicine 100(1): 105-114
Telang, M.; Reyniak, J.V.; Shulman, S. 1978: Antibodies to spermatozoa. VIII. Correlation of sperm antibody activity with postcoital tests in infertile couples International Journal of Fertility 23(3): 200-206
Ammannati, P.; Siravo, D.; Conte, B. 1989: A pharmacological and clinical review on the activity of a bovine factor VIIi derivative obtained by enzymatic hydrolysis La Clinica Terapeutica 128(4): 271-290
Piedras, J.; Sánchez-Montero, P.E.; Herrera, F.M.; Córdova, M.S.; Sánchez-Medal, L. 1993: Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate Archives of Medical Research 24(1): 23-26
Rosén, S. 2001: A rebuttal: Issues with the assay of factor VIII activity in plasma and factor VII concentrates Thrombosis and Haemostasis 86(4): 1132-1133
Allain, J.P. 1972: Study of the "in vivo" activity of factor VIIi or factor IX after injection of several concentrates: practical applications Nouvelle Revue Francaise d'Hematologie 12(2): 241-249
Corelli, F.; Massa, S.; Stefancich, G.; Mai, A.; Artico, M.; Panico, S.; Simonetti, N. 1987: Antibacterial and antifungal compounds. VIII. Synthesis and antifungal activity of pyrrol derivatives similar to trichostatin a Il Farmaco; Edizione Scientifica 42(12): 893-903
Ihle, J.N.; Keller, J.; Oroszlan, S.; Henderson, L.E.; Copeland, T.D.; Fitch, F.; Prystowsky, M.B.; Goldwasser, E.; Schrader, J.W.; Palaszynski, E.; Dy, M.; Lebel, B. 1983: Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity Journal of Immunology 131(1): 282-287
Gatzounis, R.; Schrooten, M.G.S.; Crombez, G.; Vlaeyen, J.W.S. 2018: Activity interruptions by pain impair activity resumption, but not more than activity interruptions by other stimuli: an experimental investigation Pain 159(2): 351-358
Vitali, C.; Bencivelli, W.; Isenberg, D.A.; Smolen, J.S.; Snaith, M.L.; Sciuto, M.; Neri, R.; Bombardieri, S. 1992: Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE Clinical and Experimental Rheumatology 10(5): 541-547
Tran, T.H.; Duckert, F. 1983: Dissociation of factor VIIi procoagulant antigen VIII:CAg and factor VIIi related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag Thrombosis and Haemostasis 50(2): 547-551